Identification and characterization of natural microbial products that alter the free d-aspartate content of mammalian cells

Bioorg Med Chem Lett. 2016 Jan 15;26(2):556-560. doi: 10.1016/j.bmcl.2015.11.073. Epub 2015 Nov 28.

Abstract

Mammalian cells possess the molecular apparatus necessary to take up, degrade, synthesize, and release free d-aspartate, which plays an important role in physiological functions within the body. Here, biologically active microbial compounds and pre-existing drugs were screened for their ability to alter the intracellular d-aspartate level in mammalian cells, and several candidate compounds were identified. Detailed analytical studies suggested that two of these compounds, mithramycin A and geldanamycin, suppress the biosynthesis of d-aspartate in cells. Further studies suggested that these compounds act at distinct sites within the cell. These compounds may advance our current understanding of biosynthesis of d-aspartate in mammals, a whole picture of which remains to be disclosed.

Keywords: Geldanamycin; Mithramycin A; Natural products; d-Amino acid; d-Aspartate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Transport System X-AG / metabolism
  • Animals
  • Aspartic Acid / antagonists & inhibitors*
  • Aspartic Acid / biosynthesis
  • Benzoquinones / pharmacology*
  • HEK293 Cells
  • Humans
  • Lactams, Macrocyclic / pharmacology*
  • PC12 Cells
  • Plicamycin / analogs & derivatives*
  • Plicamycin / pharmacology
  • Rats
  • Sesquiterpenes / pharmacology
  • Stereoisomerism

Substances

  • Amino Acid Transport System X-AG
  • Benzoquinones
  • Lactams, Macrocyclic
  • Sesquiterpenes
  • Aspartic Acid
  • heptelidic acid
  • mithramycin A
  • Plicamycin
  • geldanamycin